Tobira Therapeutics' Convertible Note Round

Tobira Therapeutics raised a round of funding on March 09, 2015.

Tobira is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapies to treat liver disease, inflammation, fibrosis and HIV. The company's lead product, c…

Articles about Tobira Therapeutics' Convertible Note Round: